Abstract
Optimal treatment for patients suffering from gastrointestinal stromal tumors (GIST) is based on an interdisciplinary treatment approach. Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine issued this manuscript on a consensual base within the context of currently available and published literature. This paper contains guidelines and recommendations for diagnosis, therapy, and follow-up of GIST patients in Austria.
Publication types
-
Consensus Development Conference
-
Practice Guideline
MeSH terms
-
Adult
-
Aftercare*
-
Austria
-
Benzamides / therapeutic use
-
Biopsy
-
Child
-
Combined Modality Therapy
-
Cooperative Behavior
-
Diagnosis, Differential
-
Diagnostic Imaging
-
Disease Progression
-
Endoscopy, Gastrointestinal
-
Follow-Up Studies
-
Gastrointestinal Neoplasms / diagnosis*
-
Gastrointestinal Neoplasms / genetics
-
Gastrointestinal Neoplasms / pathology
-
Gastrointestinal Neoplasms / surgery*
-
Gastrointestinal Stromal Tumors / diagnosis*
-
Gastrointestinal Stromal Tumors / genetics
-
Gastrointestinal Stromal Tumors / pathology
-
Gastrointestinal Stromal Tumors / surgery*
-
Gastrointestinal Tract / pathology
-
Gastrointestinal Tract / surgery
-
Humans
-
Imatinib Mesylate
-
Indoles / therapeutic use
-
Interdisciplinary Communication
-
Mitotic Index
-
Neoadjuvant Therapy
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / genetics
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / surgery
-
Neoplasm Staging
-
Neoplasms, Multiple Primary / diagnosis
-
Neoplasms, Multiple Primary / pathology
-
Neoplasms, Multiple Primary / surgery
-
Nomograms
-
Palliative Care
-
Phenylurea Compounds / therapeutic use
-
Piperazines / therapeutic use
-
Proto-Oncogene Proteins c-kit / genetics
-
Pyridines / therapeutic use
-
Pyrimidines / therapeutic use
-
Pyrroles / therapeutic use
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Sunitinib
Substances
-
Benzamides
-
Indoles
-
Phenylurea Compounds
-
Piperazines
-
Pyridines
-
Pyrimidines
-
Pyrroles
-
regorafenib
-
Imatinib Mesylate
-
Proto-Oncogene Proteins c-kit
-
Sunitinib